Doximity, Inc.(DOCS)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
DOCS | 5.09 B | 34.02x | 7.30% | 25.48% | $0.84 | 17.21% | 1.06x | 0.00% | $74.33 | $17.15 |
VEEV | 45.89 B | 47.01x | 17.60% | 29.35% | $6.03 | 14.43% | 2.04x | 0.00% | $310.50 | $148.05 |
WAY | 5.08 B | 37.83x | 18.10% | 11.18% | $0.70 | 3.77% | 0.37x | 0.00% | $40.35 | $17.26 |
HTFL | 4.54 B | - | 47.60% | -55.82% | -$3.10 | -154.23% | 9.70x | 0.00% | $52.22 | $20.13 |
SDGR | 2.14 B | - | 7.50% | -20.98% | -$0.74 | -16.17% | 0.33x | 0.00% | $32.45 | $10.94 |
Peer Valuation & Performance Analysis
Peer group analysis for Doximity, Inc. (DOCS) compared to its primary competitors (including VEEV, WAY, HTFL) reveals distinct metrics. DOCS trades at a valuation premium compared to its competitors, with a P/E ratio of 34.0x versus the peer average of 6.0x (representing a 469% premium). This indicates that the market expects superior growth or commands a quality premium for DOCS. In terms of growth, DOCS's revenue growth of 7.3% lags behind the peer average of 22.7%, indicating potential market share losses or slower industry adoption. Additionally, it boasts superior profitability with a net margin of 25.5% compared to the peer average of -9.1%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• DOCS ranks #1 in P/E ratio, #5 in revenue growth, and #2 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-05 | $28.01 | $28.90 | $28.01 | $28.58 | 3,164,000 | +2.33% |
| 2026-10-02 | $28.93 | $29.20 | $27.80 | $27.93 | 2,672,100 | -2.00% |
| 2026-10-01 | $28.91 | $28.95 | $28.07 | $28.50 | 3,340,600 | +0.56% |
| 2026-09-30 | $26.71 | $28.63 | $26.68 | $28.34 | 4,955,400 | +6.86% |
| 2026-09-29 | $26.33 | $27.01 | $25.84 | $26.52 | 3,269,300 | +1.22% |
| 2026-09-28 | $26.04 | $26.71 | $25.33 | $26.20 | 3,035,500 | -0.57% |
| 2026-09-25 | $25.93 | $26.62 | $25.72 | $26.35 | 2,006,100 | +1.19% |
| 2026-09-24 | $26.47 | $26.96 | $26.03 | $26.04 | 2,470,500 | -1.99% |
| 2026-09-23 | $26.64 | $27.00 | $26.34 | $26.57 | 2,473,900 | +0.23% |
| 2026-09-22 | $27.27 | $27.48 | $26.23 | $26.51 | 2,407,500 | -1.23% |
| 2026-09-21 | $26.50 | $26.86 | $26.30 | $26.84 | 2,622,900 | +2.80% |
| 2026-09-18 | $26.55 | $26.86 | $25.95 | $26.11 | 7,207,100 | -1.73% |
| 2026-09-17 | $26.02 | $26.61 | $25.55 | $26.57 | 2,171,200 | +2.43% |
| 2026-09-16 | $25.56 | $26.42 | $25.53 | $25.94 | 2,306,400 | +0.50% |
| 2026-09-15 | $26.02 | $26.82 | $25.57 | $25.81 | 2,558,800 | -2.20% |
Explore More Analysis for DOCS
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.